Sturm, Ruger & Company (RGR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
Launched a dedicated shareholder website for the 2026 Annual Meeting, providing comprehensive materials on board composition, capital stewardship, shareholder returns, and strategic direction.
Over the past two decades, delivered more than 1,100% total shareholder return, with about 600% from cumulative dividends, significantly outperforming industry peers and market indices.
Adopted the Ruger 2030 strategy, focusing on innovation, operational excellence, and disciplined capital allocation to drive long-term growth and market share.
Returned over $900 million to shareholders since 2006 through dividends and share repurchases, while reinvesting nearly $500 million in manufacturing.
Achieved nearly 10% U.S. firearms market share as of Q3 2025, despite industry contraction.
Voting matters and shareholder proposals
The 2026 Annual Meeting will include the election of directors and other proposals, with details to be provided in the forthcoming proxy statement.
Shareholders are encouraged to review the proxy statement and related materials when available for important voting information.
Board of directors and corporate governance
Board refreshed with five new directors in the past year, bringing expertise in executive management, finance, operations, and risk management.
All directors are elected annually, with proxy access, majority independent board, and no supermajority voting requirements.
Board committees include Audit, Compensation, Nominating & Corporate Governance, and Capital Policy, with regular self-evaluations and executive sessions.
Adopted a limited-duration stockholder rights plan effective October 2025 to October 2026.
Latest events from Sturm, Ruger & Company
- Ruger’s board rebuffed Beretta’s control efforts, reinforcing governance and shareholder protections.RGR
Proxy Filing10 Mar 2026 - Beretta’s bid for board control prompts defensive measures and governance refreshment.RGR
Proxy Filing9 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Sales growth and innovation offset market declines, but profitability fell year-over-year.RGR
Q4 20252 Mar 2026 - Q2 sales and profit declined, but new products and efficiency gains support future growth.RGR
Q2 20242 Feb 2026 - Q3 2024 sales rose 1.2% to $122.3M, but EPS and net income declined on margin pressure.RGR
Q3 202417 Jan 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Q4 sales and earnings rebounded on new product strength and market share gains.RGR
Q4 202423 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025